Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Alonso

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
Revista Espanola De Cardiologia (English Ed.)|December 4, 2016
Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up RegistryAdriana Saltijeral, Leopoldo Pérez de Isla, Rodrigo Alonso, et al.
BMJ Open|August 18, 2019
Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trialAurora Paez-Vega, Sara Cantisan, José Manuel Vaquero, et al.
BMC Infectious Diseases|May 4, 2023
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analysesRodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 27, 2021
Adherence to a Mediterranean diet, dyslipidemia and inflammation in familial hypercholesterolemiaLuiza Antoniazzi, Raquel Arroyo-Olivares, Marcio S Bittencourt, et al.
Lipids in Health and Disease|June 14, 2011
Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)Nelva Mata, Rodrigo Alonso, Lina Badimón, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 10, 2026
Real-life experience with maribavir for the treatment of cytomegalovirus infection in solid organ transplant recipientsJorge Boán, Carlos Aizpurúa, Isabel Rodríguez-Goncer, et al.
Journal of Clinical Lipidology|September 1, 2016
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registryRodrigo Alonso, Jose Luis Díaz-Díaz, Francisco Arrieta, et al.
Atherosclerosis|April 17, 2019
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemiaJosé Pablo Miramontes-González, Ricardo Usategui-Martín, Leopoldo Pérez de Isla, et al.
Infectious Diseases and Therapy|September 15, 2025
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?Abiu Sempere, Rodrigo Alonso, Leire Berrocal, et al.
Clinical Transplantation|March 3, 2026
Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary HypertensionPedro Manso Tejerina, Quezada Loaiza, Carlos Andrés, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
Revista Espanola De Cardiologia (English Ed.)|December 4, 2016
Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up RegistryAdriana Saltijeral, Leopoldo Pérez de Isla, Rodrigo Alonso, et al.
BMJ Open|August 18, 2019
Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trialAurora Paez-Vega, Sara Cantisan, José Manuel Vaquero, et al.
BMC Infectious Diseases|May 4, 2023
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analysesRodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 27, 2021
Adherence to a Mediterranean diet, dyslipidemia and inflammation in familial hypercholesterolemiaLuiza Antoniazzi, Raquel Arroyo-Olivares, Marcio S Bittencourt, et al.
Lipids in Health and Disease|June 14, 2011
Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)Nelva Mata, Rodrigo Alonso, Lina Badimón, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 10, 2026
Real-life experience with maribavir for the treatment of cytomegalovirus infection in solid organ transplant recipientsJorge Boán, Carlos Aizpurúa, Isabel Rodríguez-Goncer, et al.
Journal of Clinical Lipidology|September 1, 2016
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registryRodrigo Alonso, Jose Luis Díaz-Díaz, Francisco Arrieta, et al.
Atherosclerosis|April 17, 2019
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemiaJosé Pablo Miramontes-González, Ricardo Usategui-Martín, Leopoldo Pérez de Isla, et al.
Infectious Diseases and Therapy|September 15, 2025
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?Abiu Sempere, Rodrigo Alonso, Leire Berrocal, et al.
Clinical Transplantation|March 3, 2026
Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary HypertensionPedro Manso Tejerina, Quezada Loaiza, Carlos Andrés, et al.
Pageof 23